Zobrazeno 1 - 10
of 267
pro vyhledávání: '"J. Peace"'
Autor:
Michael Hurwitz, Mark Stein, Jeffrey Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Meredith M Regan, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Paul J Catalano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background As part of a partitioned survival analysis, treatment-free survival (TFS) can characterize the overall survival time patients spend between the cessation of immunotherapy and the start of subsequent therapy; both with and without toxicity.
Externí odkaz:
https://doaj.org/article/23ac543db705415f93126b90c7cd9853
Autor:
Alessia Cimadamore, Michael Hurwitz, Mark Stein, Sabina Signoretti, Jeffrey A Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Thomas Denize, Catherine J Wu, David Braun, Paul J Catalano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background To determine the efficacy and toxicity of nivolumab monotherapy in treatment-naïve patients with non-clear cell renal cell carcinoma (nccRCC) and the efficacy of nivolumab/ipilimumab salvage therapy in patients with tumors unresponsive to
Externí odkaz:
https://doaj.org/article/f31aca68bfec4407896225ae6d30cdbd
Autor:
Maria Walls, Gerard M. Walls, Jacqueline A. James, Kyle T. Crawford, Hossam Abdulkhalek, Tom B. Lynch, Aaron J. Peace, Terry E. McManus, O. Rhun Evans
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background ALK-rearrangement is observed in
Externí odkaz:
https://doaj.org/article/8eb61151eb164e278ed547c8ac169ab2
Autor:
Michael B. Atkins, Opeyemi A. Jegede, Naomi B. Haas, David F. McDermott, Mehmet A. Bilen, Mark Stein, Jeffrey A. Sosman, Robert Alter, Elizabeth R. Plimack, Moshe Ornstein, Michael Hurwitz, David J. Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J. Wu, David Braun, David Einstein, Paul J. Catalano, Hans Hammers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(25)
PURPOSE To determine the value of tumor cell programmed death-ligand 1 (PD-L1) expression as a predictive biomarker of nivolumab monotherapy efficacy in treatment-naive patients with clear cell renal cell carcinoma (ccRCC) and the efficacy of salvage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::941d4d848afe1cc0b7e6ec34f045e28e
https://pubmed.ncbi.nlm.nih.gov/35679526
https://pubmed.ncbi.nlm.nih.gov/35679526
Autor:
William J. Peace
Few figures in modern American anthropology have been more controversial or influential than Leslie A. White (1900–1975). Between the early 1940s and mid-1960s, White's work was widely discussed, and he was among the most frequently cited American
Publikováno v:
Nature Genetics. 55:534-535
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b28920940a6b19515e8ffd1ad7b172a
https://doi.org/10.1038/s41588-023-01360-8
https://doi.org/10.1038/s41588-023-01360-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel P. Petrylak, Lawrence Fong, Charles G. Drake, Mark N. Stein, Douglas G. McNeel, Ravi A. Madan, James L. Gulley, Neil H. Bander, Tomasz M. Beer, Stacey Harrelson, Philip W. Kantoff, William K. Oh, David J. Peace, Hank Porterfield, Oliver Sartor, Neal D. Shore, Susan F. Slovin, Johannes Vieweg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have been approved or are currently being invest
Externí odkaz:
https://doaj.org/article/95b49601510e476591b41345b52e8b6d
Autor:
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David Braun, David Einstein, Paul J Catalano, Hans Hammers
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e004780
BackgroundTo determine the efficacy and toxicity of nivolumab monotherapy in treatment-naïve patients with non-clear cell renal cell carcinoma (nccRCC) and the efficacy of nivolumab/ipilimumab salvage therapy in patients with tumors unresponsive to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03edb62350315f2f9e07a52ce5ff4b7
https://doi.org/10.1136/jitc-2022-004780
https://doi.org/10.1136/jitc-2022-004780